Abstract
Quantification of local similarity between protein 3D structures is a promising tool in computer-aided drug design and prediction of biological function. Over the last ten years, several computational methods were proposed, mostly based on geometrical comparisons. This review summarizes the recent literature and gives an overview of available programs. A particular interest is given to the underlying methodologies. Our analysis points out strengths and weaknesses of the various approaches. If all described methods work relatively well when two binding sites obviously resemble each other, scoring potential solutions remains a difficult issue, especially if the similarity is low. The other challenging question is the protein flexibility, which is indeed difficult to evaluate from a static representation. Last, most of recently developed techniques are fast and can be applied to large amounts of data. Examples were carefully chosen to illustrate the wide applicability domain of the most popular methods: detection of common structural motifs, identification of secondary targets for a drug-like compound, comparison of binding sites across a functional family, comparison of homology models, database screening.
Keywords: Local similarity, three-dimensional comparison, protein structure, binding site, molecular shape, drug design, function assignment
Current Computer-Aided Drug Design
Title: How to Measure the Similarity Between Protein Ligand-Binding Sites?
Volume: 4 Issue: 3
Author(s): Esther Kellenberger, Claire Schalon and Didier Rognan
Affiliation:
Keywords: Local similarity, three-dimensional comparison, protein structure, binding site, molecular shape, drug design, function assignment
Abstract: Quantification of local similarity between protein 3D structures is a promising tool in computer-aided drug design and prediction of biological function. Over the last ten years, several computational methods were proposed, mostly based on geometrical comparisons. This review summarizes the recent literature and gives an overview of available programs. A particular interest is given to the underlying methodologies. Our analysis points out strengths and weaknesses of the various approaches. If all described methods work relatively well when two binding sites obviously resemble each other, scoring potential solutions remains a difficult issue, especially if the similarity is low. The other challenging question is the protein flexibility, which is indeed difficult to evaluate from a static representation. Last, most of recently developed techniques are fast and can be applied to large amounts of data. Examples were carefully chosen to illustrate the wide applicability domain of the most popular methods: detection of common structural motifs, identification of secondary targets for a drug-like compound, comparison of binding sites across a functional family, comparison of homology models, database screening.
Export Options
About this article
Cite this article as:
Kellenberger Esther, Schalon Claire and Rognan Didier, How to Measure the Similarity Between Protein Ligand-Binding Sites?, Current Computer-Aided Drug Design 2008; 4(3) . https://dx.doi.org/10.2174/157340908785747401
DOI https://dx.doi.org/10.2174/157340908785747401 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Virtual Screening of Chinese Medicine Small Molecule Compounds Targeting SARS-CoV-2 3CL Protease (3CL pro)
Letters in Drug Design & Discovery Recombinant Activated Factor VII as a General Haemostatic Agent:Evidence-Based Efficacy and Safety
Current Drug Safety QSAR Based Design of New Antitubercular Compounds: Improved Isoniazid Derivatives Against Multidrug-Resistant TB
Current Pharmaceutical Design Substituted Benzimidazole Derivatives as Angiotensin II -AT1 Receptor Antagonist: A Review
Mini-Reviews in Medicinal Chemistry Considering Environmental Health and Energy Resources to Design Transformers
Current Signal Transduction Therapy COVID-19 and ARDS: Update on Preventive and Therapeutic Venues
Current Molecular Medicine Potential Therapeutic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in the Context of Ischemic Heart Failure: A State-of-the-Art Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Important Classes of Bioactive Alkaloids from Marine Ascidians: Structures, Isolation and Bioactivity
Current Topics in Medicinal Chemistry Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization
Anti-Cancer Agents in Medicinal Chemistry Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents
Mini-Reviews in Medicinal Chemistry The In Silico Prediction of Human-Specific Metabolites from Hepatotoxic Drugs
Current Drug Discovery Technologies Targeting the Fatty Acid Transport Proteins (FATP) to Understand the Mechanisms Linking Fatty Acid Transport to Metabolism
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Harnessing the Natural Pool of Polyketide and Non-ribosomal Peptide Family: A Route Map towards Novel Drug Development
Current Molecular Pharmacology Attenuation of Bleomycin-Induced Pulmonary Fibrosis by Intratracheal Administration of Antisense Oligonucleotides Against Angiotensinogen mRNA
Current Pharmaceutical Design Impact of Indazole Scaffold as Antibacterial and Antifungal Agent
Current Topics in Medicinal Chemistry Computational Approaches for the Discovery of Cysteine Protease Inhibitors Against Malaria and SARS
Current Computer-Aided Drug Design Challenges Associated with Current and Future TB Treatment
Infectious Disorders - Drug Targets Delirium in Older Patients – A Review
Current Psychiatry Reviews Design, Synthesis and Biological Evaluation of Novel 1, 3- thiazolidine-2, 4-diones as Anti-prostate Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry HMGB1-Directed Drug Discovery Targeting Cutaneous Inflammatory Dysregulation
Current Drug Metabolism